WallStreetZenWallStreetZen

NASDAQ: ESPR
Esperion Therapeutics Inc Stock Ownership - Who owns Esperion Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Esperion Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric WarrenChief Commercial Officer2024-05-17192$2.48
$476.74Sell
Eric WarrenChief Commercial Officer2023-09-20742$1.25
$923.79Sell
Eric WarrenChief Commercial Officer2023-08-18243$1.41
$343.60Sell
Eric WarrenChief Commercial Officer2023-07-19106$1.59
$168.01Sell
Eric WarrenChief Commercial Officer2023-06-21603$1.48
$894.25Sell

1 of 1

ESPR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESPR insiders and whales buy or sell their stock.

ESPR Shareholders

What type of owners hold Esperion Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC7.24%13,708,731$31.39MInstitution
Bellevue Group Ag5.25%9,944,064$22.77MInstitution
Wasatch Advisors LP4.82%9,129,647$20.91MInstitution
Vanguard Group Inc4.66%8,826,546$20.21MInstitution
Great Point Partners LLC4.22%8,000,000$18.32MInstitution
Woodline Partners LP4.18%7,922,229$18.14MInstitution
Millennium Management LLC3.00%5,681,744$13.01MInstitution
D E Shaw Co Inc2.71%5,143,486$11.78MInstitution
Bank Of America Corp2.40%4,545,260$10.41MInstitution
Target N. V. Biotech2.36%4,477,964$10.25MInsider

1 of 3

ESPR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESPR66.12%20.81%Net SellingNet Selling
ORGO6.06%93.94%Net SellingNet Buying
PROC0.08%76.27%
KMDA9.87%0.00%
EBS42.28%57.72%Net SellingNet Selling
View Top Pharmaceutical Stocks

Esperion Therapeutics Stock Ownership FAQ

Who owns Esperion Therapeutics?

Esperion Therapeutics (NASDAQ: ESPR) is owned by 66.12% institutional shareholders, 20.81% Esperion Therapeutics insiders, and 13.07% retail investors. Target N. V. Biotech is the largest individual Esperion Therapeutics shareholder, owning 4.48M shares representing 2.36% of the company. Target N. V. Biotech's Esperion Therapeutics shares are currently valued at $9.67M.

If you're new to stock investing, here's how to buy Esperion Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.